|
1
|
Garnero P, Sornay-Rendu E, Duboeuf F and
Delmas PD: Markers of bone turnover predict postmenopausal forearm
bone loss over 4 years: The OFELY study. J Bone Miner Res.
14:1614–1621. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernlund E, Svedbom A, Ivergård M,
Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B and Kanis
JA: Osteoporosis in the European union: Medical management,
epidemiology and economic burden. A report prepared in
collaboration with the International Osteoporosis Foundation (IOF)
and the European Federation of Pharmaceutical Industry Associations
(EFPIA). Arch Osteoporos. 8:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
An J, Yang H, Zhang Q, Liu C, Zhao J,
Zhang L and Chen B: Natural products for treatment of osteoporosis:
The effects and mechanisms on promoting Osteoblast-mediated bone
formation. Life Sci. 147:46–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee CJ, Shim KS and Ma JY: Artemisia
capillaris alleviates bone loss by stimulating osteoblast
mineralization and suppressing osteoclast differentiation and bone
resorption. Am J Chin Med. 44:1675–1691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SH, Lee JY, Kwon YI and Jang HD:
Anti-Osteoclastic activity of Artemisia capillaris thunb.
Extract depends upon attenuation of osteoclast differentiation and
bone Resorption-associated acidification due to chlorogenic acid,
hyperoside, and scoparone. Int J Mol Sci. 18:3222017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu YP, Qiu XY, Liu Y and Ma G: Research
progress on the pharmacological effects of Artemisiae Scopariae
Herba. Chinese Traditional and Herbal Drugs. 50:2235–2241.
2019.(In Chinese).
|
|
7
|
Witaicenis A, Seito LN, Da Silveira Chagas
A, de Almeida LD Jr, Luchini AC, Rodrigues-Orsi P, Cestari SH and
Di Stasi LC: Antioxidant and intestinal Anti-inflammatory effects
of Plant-derived coumarin derivatives. Phytomedicine. 21:240–246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeinali M, Rezaee SA and Hosseinzadeh H:
An overview on immunoregulatory and Anti-inflammatory properties of
chrysin and flavonoids Substances. Biomed Pharmacother.
92:998–1009. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta A, Atanasov AG, Li Y, Kumar N and
Bishayee A: Chlorogenic acid for cancer prevention and therapy:
Current status on efficacy and mechanisms of Action. Pharmacol Res.
186:1065052022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding J, Wang L, He C, Zhao J, Si L and
Huang H: Artemisia scoparia: Traditional uses, active
constituents and pharmacological effects. J Ethnopharmacol.
273:1139602021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gan DL, Yao Y, Su HW, Huang YY, Shi JF,
Liu XB and Xiang MX: Volatile oil of Platycladus orientalis
(L.) Franco leaves exerts strong Anti-inflammatory effects via
inhibiting the IκB/NF-κB pathway. Curr Med Sci. 41:180–186. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou RP, Deng MT, Chen LY, Fang N, Du C,
Chen LP, Zou YQ, Dai JH, Zhu ML, Wang W, et al: Shp2 regulates
chlorogenic acid-induced proliferation and adipogenic
differentiation of bone Marrow-derived mesenchymal stem cells in
adipogenesis. Mol Med Rep. 11:4489–4495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu T, Wu X, Zhou Z, Ye Y, Yan C, Zhuge N
and Yu J: Hyperoside ameliorates periodontitis in rats by promoting
osteogenic differentiation of BMSCs via activation of the NF-κB
pathway. FEBS Open Bio. 10:1843–1855. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han D, Chen W, Gu X, Shan R, Zou J, Liu G,
Shahid M, Gao J and Han B: Cytoprotective effect of chlorogenic
acid against hydrogen Peroxide-induced oxidative stress in MC3T3-E1
cells through PI3K/Akt-mediated Nrf2/HO-1 signaling pathway.
Oncotarget. 8:14680–14692. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Folwarczna J, Pytlik M, Zych M, Cegieła U,
Nowinska B, Kaczmarczyk-Sedlak I, Sliwinski L, Trzeciak H and
Trzeciak HI: Effects of caffeic and chlorogenic acids on the rat
skeletal system. Eur Rev Med Pharmacol Sci. 19:682–693.
2015.PubMed/NCBI
|
|
16
|
Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee
MS, Rho MC and Oh J: Chlorogenic acid inhibits osteoclast
differentiation and bone resorption by down-regulation of receptor
activator of nuclear factor kappa-B ligand-induced nuclear factor
of activated T cells c1 expression. Biol Pharm Bull. 36:1779–1786.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SH and Jang HD: Scoparone attenuates
RANKL-induced osteoclastic differentiation through controlling
reactive oxygen species production and scavenging. Exp Cell Res.
331:267–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
An H, Chu C, Zhang Z, Zhang Y, Wei R, Wang
B, Xu K, Li L, Liu Y, Li G and Li X: Hyperoside alleviates
postmenopausal osteoporosis via regulating miR-19a-5p/IL-17A axis.
Am J Reprod Immunol. 90:e137092023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SH, Ding Y, Yan XT, Kim YH and Jang
HD: Scopoletin and scopolin isolated from Artemisia
iwayomogi suppress differentiation of osteoclastic macrophage
RAW 264.7 cells by scavenging reactive oxygen species. J Nat Prod.
76:615–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to Gpx4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP Cyclohydrolase
1/Tetrahydrobiopterin Counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
Ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang Z, Qi G, He X, Yu Y, Cao Y, Zhang C,
Zou W and Yuan H: Ferroptosis in osteocytes as a target for
protection against postmenopausal osteoporosis. Adv Sci (Weinh).
2024:e23073882024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim TE, Jo YH and Kim CT: Improvement of
quality characteristics of mulberry (Morus alba L.) fruit
extract using high-pressure enzymatic treatment. Food Bioprocess
Technol. 17:4106–4114. 2024. View Article : Google Scholar
|
|
29
|
Gnoumou E, Tran TA, Yang TT, Quach TT and
Wang CY: Antibacterial, anti-inflammatory and anti-osteoclastogenic
effects of synthetic mineralized lysozyme nanoparticles for
treating infectious osteoporosis. Int J Biol Macromol.
320:1457692025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li P, Dai J, Li Y, Alexander D, Čapek J,
Geis-Gerstorfer J, Wan G, Han J, Yu Z and Li A: Zinc based
biodegradable metals for bone repair and regeneration: Bioactivity
and molecular mechanisms. Mater Today Bio. 25:1009322024.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pietrangelo A: Iron and the Liver. Liver
Int. 36 (Suppl 1):S116–S123. 2016. View Article : Google Scholar
|
|
32
|
Wu Z, Zhu Y, Liu W, Balasubramanian B, Xu
X, Yao J and Lei X: Ferroptosis in liver disease: Natural active
compounds and therapeutic implications. Antioxidants (Basel).
13:3522024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karadeniz F, Oh JH, Lee JI, Seo Y and Kong
CS: 3,5-dicaffeoyl-epi-quinic acid from Atriplex gmelinii
enhances the osteoblast differentiation of bone marrow-derived
human mesenchymal stromal cells via WnT/BMP signaling and
suppresses adipocyte differentiation via AMPK activation.
Phytomedicine. 71:1532252020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bauer NB, Khassawna TE, Goldmann F, Stirn
M, Ledieu D, Schlewitz G, Govindarajan P, Zahner D, Weisweiler D,
Schliefke N, et al: Characterization of bone turnover and energy
metabolism in a rat model of primary and secondary osteoporosis.
Exp Toxicol Pathol. 67:287–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Komori T: Whole aspect of Runx2 functions
in skeletal development. Int J Mol Sci. 23:57762022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fakhry M, Hamade E, Badran B, Buchet R and
Magne D: Molecular mechanisms of mesenchymal stem cell
differentiation towards osteoblasts. World J Stem Cells. 5:136–148.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee B, Thirunavukkarasu K, Zhou L, Pastore
L, Baldini A, Hecht J, Geoffroy V, Ducy P and Karsenty G: Missense
mutations abolishing DNA binding of the osteoblast-specific
transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat
Genet. 16:307–310. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ozaki Y, Koide M, Furuya Y, Ninomiya T,
Yasuda H, Nakamura M, Kobayashi Y, Takahashi N, Yoshinari N and
Udagawa N: Treatment of OPG-deficient mice with WP9QY, a
Rankl-binding peptide, recovers alveolar bone loss by suppressing
osteoclastogenesis and enhancing osteoblastogenesis. PLoS One.
12:e01849042017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu R, Wang Z, Xu Y, Wan H, Zhang X, Song
M, Yang H, Chai Y and Yu B: High-fat diet increases bone loss by
inducing ferroptosis in osteoblasts. Stem Cells Int.
2022:93594292022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang Y, Lin Y, Wang M, Yuan K, Wang Q, Mu
P, Du J, Yu Z, Yang S, Huang K, et al: Targeting ferroptosis
suppresses osteocyte glucolipotoxicity and alleviates diabetic
osteoporosis. Bone Res. 10:262022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Ma H, Sun J, Zheng T, Zhao P, Li H
and Yang M: Mitochondrial ferritin deficiency promotes osteoblastic
ferroptosis via mitophagy in type 2 diabetic osteoporosis. Biol
Trace Elem Res. 200:298–307. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zimmermann MB and Hurrell RF: Nutritional
iron deficiency. Lancet. 370:511–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Clark SF: Iron deficiency anemia. Nutr
Clin Pract. 23:128–141. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shen GS, Yang Q, Jian JL, Zhao GY, Liu LL,
Wang X, Zhang W, Huang X and Xu YJ: Hepcidin1 knockout mice display
defects in bone microarchitecture and changes of bone formation
markers. Calcif Tissue Int. 94:632–639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu H, Lian L, Shi D, Zhao H and Dai Y:
Hepcidin promotes osteogenic differentiation through the bone
morphogenetic protein 2/small mothers against decapentaplegic and
mitogen-activated protein kinase/P38 signaling pathways in
mesenchymal stem cells. Mol Med Rep. 11:143–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fang Y, Chen X, Tan Q, Zhou H, Xu J and Gu
Q: Inhibiting ferroptosis through disrupting the NCOA4-FTH1
interaction: A new mechanism of action. ACS Cent Sci. 7:980–989.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu P, Zhang Z, Cai Y, Li Z, Zhou Q and
Chen Q: Ferroptosis: Mechanisms and role in diabetes mellitus and
its complications. Ageing Res Rev. 94:1022012024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Le Y, Liu Q, Yang Y, Stanford D, Freeman
WM and Ding XQ: The emerging role of nuclear receptor coactivator 4
in health and disease: A novel bridge between iron metabolism and
Immunity. Cell Death Discov. 10:3122024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Z, Ji C, Wang YN, Liu S, Wang M, Xu
X and Zhang D: Maresin1 Suppresses High-Glucose-induced ferroptosis
in osteoblasts via NRF2 Activation in type 2 diabetic osteoporosis.
Cells. 11:25602022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kuang F, Liu J, Xie Y, Tang D and Kang R:
MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic
cancer cells. Cell Chem Biol. 28:765–775.e5. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M,
Buchfelder M and Savaskan N: Nrf2-Keap1 pathway promotes cell
proliferation and diminishes ferroptosis. Oncogenesis. 6:e3712017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rojo de la Vega M, Chapman E and Zhang DD:
NRF2 and the hallmarks of cancer. Cancer Cell. 34:21–43. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen Y, Jiang Z and Li X: New insights
into crosstalk between Nrf2 pathway and ferroptosis in lung
disease. Cell Death Dis. 15:8412024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Živanović N, Lesjak M, Simin N and Srai
SKS: Beyond mortality: Exploring the influence of plant phenolics
on modulating Ferroptosis-A systematic review. Antioxidants
(Basel). 13:3342024. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhou HM, Liu Y, Shi F, Qiu HW, Li L, Shu
QP, Liu YY, Wang BQ, Gao M, Du RL, et al: CLK2 Regulates the
KEAP1/NRF2 and p53 pathways to suppress ferroptosis in colorectal
cancer. Cancer Res. 85:4734–4750. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Duan CH and Jiang LL: High-dose Yin Chen
combined with Western medicine for liver protection in treating
acute icteric hepatitis. Youjiang Med J. 3832001.
|
|
57
|
Chen GE and Huang XD: Large dose of Yin
Chen in the treatment of 84 cases of acute infectious icteric
hepatitis: A therapeutic effect observation. Jilin J Tradit Chin
Med. 191984.
|
